New Cellgorithm™ data presented at ISSCR symposium indicates faster, scalable cell programming and add to Syntax Bio’s ...
Syntax, a New York-based fintech company pioneering economic data intelligence and next-generation index technologies, today announced a deep technology integration with Schwab Advisor Services™, ...
Syntax Direct now integrates directly to Schwab's iRebal, letting advisors build and apply custom indices to client accounts ...
Syntax Bio, a privately held synthetic biology company focused on cell therapies, on Sunday said it expanded its Series A financing round to $14.4 million, bringing total funding raised to more than ...
Cell therapies are already here, with treatments now available for some cancers and rare diseases. But bringing such living medicines to more patients presents both scientific and financial challenges ...
CHICAGO-- (BUSINESS WIRE)-- Syntax Bio will present new research on its Cellgorithm™ cell-programming platform at the ...
If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results